Skip to main content

Table 2 Antibiotic resistance profiles for Recto-vaginal colonizing group B streptococcal isolates, Northwest Ethiopia

From: Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis

Antibiotics

GBS isolates (n = 98)

Susceptible, n (%)

Intermediate, n (%)

Resistant, n (%)

Penicillin

88 (89.8)

0 (0.0)

10 (10.2)

Ampicillin

89 (90.8)

0 (0.0)

9 (9.2)

Erythromycin

66 (67.3)

6 (6.1)

26 (26.5)

Clindamycin

72 (73.5)

5 (5.1)

21 (21.4)a

Azithromycin

76 (77.6)

3 (3.1)

19 (19.4)

Vancomycin

82 (83.7)

0 (0.0)

16 (16.3)

Ceftriaxone

67 (68.4)

0 (0.0)

31 (31.6)

Ciprofloxacin

84 (85.7)

0 (0.0)

14 (14.3)

Chloramphenicol

83 (84.8)

4 (4.1)

11 (11.2)

Tetracycline

19 (19.4)

7 (7.1)

72 (73.4)

  1. aExcluding the inducible clindamycin resistant isolates (iMLSB)